Poland - Pharmaceutical products
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 28 April 2021
- Opportunity publication date
- 27 March 2021
- Category
- 33600000: Ph
- Value of contract
- to be confirmed
- Your guide to exporting
Description
Drug delivery
Tablets Vitamins Preparations Miscellaneous Ampoules Metamizol Anesthetics Acetylcysteine Injections Lignocaine inj Hepatitis Vaccine Milrinone Oseltamivir Enoxaparin Dexametasone Dexmedetomidine Metoclopropamide Antimicrobial Catheter Protection System for patency and infection control Octreotide Ferrum inj Acyclovir Calcium Gluconatum Etamsylate Dobutamine inj Fluconazole Hydrocortisone Kalium chloratum Metronidazole Natrium bicarbonicum Aqua pro inj - - amp amp Natrium chloratum 0,9 % Natrium chloratum 10 % Omeprazole inj Alprostadil Methylprednisolone Hemisuccinate Theophylline II Alteplase Mesna Glucose Sevelamer Ornithine II Furosemidum Rocuronium Bromide Narcotics and psychotropic drugs Ketamine Phenobarbital Sufentanyl Nadroparine Propofol MCT/LCT Syrups and other for internal use I Medicines used in oncology Gemcitabine Bleomycin Mercaptopurin Vinblastin Vinolerbine Carboplatin Cisplatin Doxorubicin Calcium folinate Dacarbazin Phosphate mouthwash Tioguanine Cyclophosphamide Ifosfamide Cytarabine Etoposide Vincristin Temozolomide Idarubicin Irinotecan Oxaliplatinum Remifentanil Human Albumin 20% External Medicine I Moisturizing catheterization gel in syringes Lidocaine + Prylocaine Intubation gel with lidocaine Intubation gel without lidocaine Nasal drops Argosulfan Lignocaine gel Probiotics Linezolid Haemostatic surgical dressing, Hyaluronic Acid Interferon b Sugammadex Adalimumab Etanercept Tobramycin nebulisation fluid Imatinib Posaconib nebulization Imatinib Posaconazole Tacrolimus Tepadine Elaprase Tecfidera Revolade Protein C Rituximab Topotecan Infliximab Tocilizumab Absorbable bone substitute Valganciclovir Amphotericin B Gonadorelin, Protirelin Dihydralazine Tetracosactide Treosulfan Amphotericin b Daunorubicine hydrochloride Dactinomycin Vindesine Triamcinolone Hexacetonide Chloramphenicol Foscarnet sodium Colistin Probenecid Labetalol Cidofovir Asparaginase Mitoxatrone Prescription Drug Products Wafers
- Opportunity closing date
- 28 April 2021
- Value of contract
- to be confirmed
About the buyer
- Address
- Uniwersytecki Szpital Dziecięcy w Lublinie ul. prof. Antoniego Gębali 6 Lublin 20-093 Poland
- Contact
- zp@uszd.lublin.pl
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.